Tokyo Tape
Sign in
← SymBio Pharmaceuticals

Annual report

4582.TEDINET S100T3FG
Period2023-01-01 → 2023-12-31
Filed2024-03-22
StandardJapan GAAP
ConsolidatedYes
Data checks23 of 23 passed
Key figures · 114
MetricValuePeriodScopeSource row
Revenue¥5.6bn2023-01-01 → 2023-12-31Cons.Net sales
Revenue¥10.0bn2022-01-01 → 2022-12-31Cons.Net sales
Operating income−¥812m2023-01-01 → 2023-12-31Cons.Operating income
Operating income¥2.0bn2022-01-01 → 2022-12-31Cons.Operating income
Ordinary income−¥736m2023-01-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥2.0bn2022-01-01 → 2022-12-31Cons.Ordinary income
Profit before tax−¥1.2bn2023-01-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥2.1bn2022-01-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)−¥2.0bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.2bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income−¥2.0bn2023-01-01 → 2023-12-31Cons.Profit loss
Net income¥1.2bn2022-01-01 → 2022-12-31Cons.Profit loss
Total assets¥8.2bnat 2023-12-31Cons.Assets
Total assets¥10.4bnat 2022-12-31Cons.Assets
Total liabilities¥960mat 2023-12-31Cons.Liabilities
Total liabilities¥1.9bnat 2022-12-31Cons.Liabilities
Net assets / equity¥7.2bnat 2023-12-31Cons.Net assets
Net assets / equity¥8.5bnat 2022-12-31Cons.Net assets
Net assets / equity¥6.7bnat 2021-12-31dCons.Net assets
Cash and deposits¥6.5bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥6.3bnat 2022-12-31Cons.Cash and deposits
Cash & equivalents¥6.5bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥6.3bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥3.9bnat 2021-12-31dCons.Cash and cash equivalents
Operating cash flow−¥195m2023-01-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.6bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥377m2023-01-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥47m2022-01-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Financing cash flow¥680m2023-01-01 → 2023-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥628m2022-01-01 → 2022-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥-49.192023-01-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.22022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥29.772022-01-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Net assets per share¥164.32at 2023-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥204.83at 2022-12-31Cons.Net assets per share (5-year summary)
Equity ratio84.9%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio77.6%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
ROE14.6%2022-01-01 → 2022-12-31Cons.Rate of return on equity (5-year summary)
Employees109at 2023-12-31Cons.Number of employees
Employees122at 2022-12-31Cons.Number of employees
Revenue¥5.6bn2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥10.0bn2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥8.3bn2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥3.0bn2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Revenue¥2.8bn2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Operating income−¥852m2023-01-01 → 2023-12-31StandaloneOperating income
Operating income¥2.0bn2022-01-01 → 2022-12-31StandaloneOperating income
Ordinary income−¥774m2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income¥2.0bn2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income¥1.0bn2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥4.6bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥4.4bn2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.2bn2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Profit before tax¥2.1bn2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Net income−¥2.0bn2023-01-01 → 2023-12-31StandaloneProfit loss
Net income¥1.2bn2022-01-01 → 2022-12-31StandaloneProfit loss
Net income¥2.0bn2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income−¥4.1bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income−¥4.4bn2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Total assets¥8.2bnat 2023-12-31StandaloneAssets
Total assets¥10.4bnat 2022-12-31StandaloneAssets
Total assets¥8.5bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥6.3bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥5.3bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥980mat 2023-12-31StandaloneLiabilities
Total liabilities¥1.9bnat 2022-12-31StandaloneLiabilities
Net assets / equity¥7.2bnat 2023-12-31StandaloneNet assets
Net assets / equity¥8.5bnat 2022-12-31StandaloneNet assets
Net assets / equity¥6.7bnat 2021-12-31dStandaloneNet assets
Net assets / equity¥4.7bnat 2020-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥4.4bnat 2019-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥6.3bnat 2023-12-31StandaloneCash and deposits
Cash and deposits¥6.3bnat 2022-12-31StandaloneCash and deposits
Cash & equivalents¥3.9bnat 2021-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.8bnat 2020-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.9bnat 2019-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥140m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥4.1bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥4.4bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥71m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥160m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥216m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥72m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥4.2bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥3.7bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-49.792023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥30.372022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥53.042021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-124.132020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-189.032019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥29.952022-01-01 → 2022-12-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥52.322021-01-01 → 2021-12-31dStandaloneDiluted earnings per share (5-year summary)
Net assets per share¥164.02at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥204.95at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥162.26at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥105.76at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥143.07at 2019-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio84.6%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio77.8%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio73.7%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio64.3%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio71.7%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE16.6%2022-01-01 → 2022-12-31StandaloneRate of return on equity (5-year summary)
ROE39.6%2021-01-01 → 2021-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued42,278,081at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued39,603,606at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued38,457,206at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued38,202,956at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued26,437,681at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees103at 2023-12-31StandaloneNumber of employees
Employees118at 2022-12-31StandaloneNumber of employees
Employees141at 2021-12-31dStandaloneNumber of employees
Employees127at 2020-12-31dStandaloneNumber of employees
Employees107at 2019-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 1
SegmentItemPeriodValue
Research And Development Manufacturing And Sales Of Pharmaceuticals Etc And Related Businessreportable segmentemployeesat 2023-12-31109 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,272
ItemContextValueUnit
Provision for office transfer expenses noePrior1YearDuration_NonConsolidatedMember－JPY
Provision for office transfer expenses noeCurrentYearDuration_NonConsolidatedMember25176000JPY
Loss on retirement of noncurrent assets noePrior1YearDuration_NonConsolidatedMember540000JPY
Loss on retirement of noncurrent assets noeCurrentYearDuration_NonConsolidatedMember7868000JPY
Non operating expensesPrior1YearDuration_NonConsolidatedMember102951000JPY
Non operating expensesCurrentYearDuration_NonConsolidatedMember57252000JPY
Ordinary incomePrior1YearDuration_NonConsolidatedMember2001204000JPY
Ordinary incomeCurrentYearDuration_NonConsolidatedMember-773822000JPY
Gain on reversal of subscription rights to shares eiPrior1YearDuration_NonConsolidatedMember106401000JPY
Gain on reversal of subscription rights to shares eiCurrentYearDuration_NonConsolidatedMember101333000JPY
Extraordinary incomePrior1YearDuration_NonConsolidatedMember106401000JPY
Extraordinary incomeCurrentYearDuration_NonConsolidatedMember101333000JPY
Impairment loss elPrior1YearDuration_NonConsolidatedMember－JPY
Impairment loss elCurrentYearDuration_NonConsolidatedMember560590000JPY
Extraordinary lossPrior1YearDuration_NonConsolidatedMember－JPY
Extraordinary lossCurrentYearDuration_NonConsolidatedMember560590000JPY
Income before income taxesPrior1YearDuration_NonConsolidatedMember2107605000JPY
Income before income taxesCurrentYearDuration_NonConsolidatedMember-1233079000JPY
Income taxes currentPrior1YearDuration_NonConsolidatedMember390552000JPY
Income taxes currentCurrentYearDuration_NonConsolidatedMember8915000JPY
Income taxes deferredPrior1YearDuration_NonConsolidatedMember531030000JPY
Income taxes deferredCurrentYearDuration_NonConsolidatedMember744728000JPY
Income taxesPrior1YearDuration_NonConsolidatedMember921582000JPY
Income taxesCurrentYearDuration_NonConsolidatedMember753643000JPY
Profit lossPrior1YearDuration_NonConsolidatedMember1186022000JPY
Profit lossCurrentYearDuration_NonConsolidatedMember-1986723000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_CapitalStockMember17157628000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_LegalCapitalSurplusMember17127628000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_OtherCapitalSurplusMember4873000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_CapitalSurplusMember17132501000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_RetainedEarningsBroughtForwardMember-27977510000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_RetainedEarningsMember-27977510000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_TreasuryStockMember-86045000JPY
Cumulative effects of changes in accounting policiesPrior2YearInstant_NonConsolidatedMember_RetainedEarningsBroughtForwardMember-92822000JPY
Cumulative effects of changes in accounting policiesPrior2YearInstant_NonConsolidatedMember_RetainedEarningsMember-92822000JPY
Restated balancePrior2YearInstant_NonConsolidatedMember_CapitalStockMember17157628000JPY
Restated balancePrior2YearInstant_NonConsolidatedMember_LegalCapitalSurplusMember17127628000JPY
Restated balancePrior2YearInstant_NonConsolidatedMember_OtherCapitalSurplusMember4873000JPY
Restated balancePrior2YearInstant_NonConsolidatedMember_CapitalSurplusMember17132501000JPY
Restated balancePrior2YearInstant_NonConsolidatedMember_RetainedEarningsBroughtForwardMember-28070332000JPY
Restated balancePrior2YearInstant_NonConsolidatedMember_RetainedEarningsMember-28070332000JPY
Restated balancePrior2YearInstant_NonConsolidatedMember_TreasuryStockMember-86045000JPY
Issuance of new sharesPrior1YearDuration_NonConsolidatedMember_CapitalStockMember331000000JPY
Issuance of new sharesPrior1YearDuration_NonConsolidatedMember_LegalCapitalSurplusMember331000000JPY
Issuance of new sharesPrior1YearDuration_NonConsolidatedMember_CapitalSurplusMember331000000JPY
Issuance of new sharesexercise of subscription rights to sharesPrior1YearDuration_NonConsolidatedMember_CapitalStockMember59831000JPY
Issuance of new sharesexercise of subscription rights to sharesPrior1YearDuration_NonConsolidatedMember_LegalCapitalSurplusMember59831000JPY
Issuance of new sharesexercise of subscription rights to sharesPrior1YearDuration_NonConsolidatedMember_CapitalSurplusMember59831000JPY
Profit lossPrior1YearDuration_NonConsolidatedMember_RetainedEarningsBroughtForwardMember1186022000JPY
Profit lossPrior1YearDuration_NonConsolidatedMember_RetainedEarningsMember1186022000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 23 of 23 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-12-31pass
balance sheet identitynon_consolidated 2022-12-31pass
balance sheet identitynon_consolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass